¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"squamous epithelial cell"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
Leydig cell tumor
¶óÀ̵ðÈ÷¼¼Æ÷Á¾¾ç
light cell
¹àÀº¼¼Æ÷
lipoid cell
ÁöÁú¼¼Æ÷
luteal cell
Ȳ(»ö)ü¼¼Æ÷
lymphoid cell
¸²ÇÁ°è¼¼Æ÷, ¸²ÇÁ¸ð¾ç¼¼Æ÷
lymphokine-activated killer cell
¸²Æ÷Ä«ÀÎȰ¼º»ìÇØ¼¼Æ÷
lymphopoietic cell
¸²ÇÁ±¸Çü¼º¼¼Æ÷
lymphosarcoma cell leukemia
¸²ÇÁÀ°Á¾¼¼Æ÷¹éÇ÷º´
lacunar cell
°ø°£¼¼Æ÷
mitotic cell
À¯»çºÐ¿±â¼¼Æ÷
mitral cell
½Â¸ð¼¼Æ÷
mixed germ cell tumor
È¥ÇÕÁ¾ÀÚ¼¼Æ÷Á¾¾ç
monocyte-macrophage cell system
´ÜÇÙ±¸Å«Æ÷½Ä¼¼Æ÷°èÅë, ´ÜÇÙ±¸´ë½Ä¼¼Æ÷°èÅë
mononuclear cell
´ÜÇÙ¼¼Æ÷, ´ÜÇÙ±¸
mossy cell
À̳¢¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
nevus cell
¸ð¹Ý¼¼Æ÷
nodal cell
°áÀý¼¼Æ÷
nucleated cell
À¯ÇÙ¼¼Æ÷
null cell
¹«Ç¥Áö¼¼Æ÷
nurse cell
(¢¡supporting cell) ¹öÆÀ¼¼Æ÷
oat cell carcinoma
±Í¸®¼¼Æ÷¾ÏÁ¾
osmiophilic cell
Ä£¿À½º¹Å¼¼Æ÷
oxyntic cell
(¢¡parietal cell) º®¼¼Æ÷
oxyphilic cell
È£»ê¼¼Æ÷
packed red blood cell
³óÃàÀûÇ÷±¸
parafollicular cell
¼ÒÆ÷°ç¼¼Æ÷
paralutein cell
ȲüÁÖÀ§¼¼Æ÷, ºÎȲü¼¼Æ÷
parietal cell
º®¼¼Æ÷
pathologic cell
º´Àû¼¼Æ÷
perivascular cell
Ç÷°üÁÖÀ§¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
IIÇü
hypersensitivity reactions,type iv(cell-mediated)
IVÇü
hypersensitivity, cell-mediated
¼¼Æ÷¸Å°³ °ú¹Î¹ÝÀÀ
hypersensitized cell
°ú°¨ÀÛ¼¼Æ÷.
hypoglycemia, beta cell tumor
ÀúÇ÷´ç(Áõ), º£Å¸¼¼Æ÷Á¾
hypoxic cell
Àú»ê¼Ò¼¼Æ÷
hypoxic cell sensitizer
Àú»ê¼Ò¼¼Æ÷°¨ÀÛÁ¦
i-cell disease
I-¼¼Æ÷º´
idiotype specific regulatory cell
°³º°Æ¯ÀÌÇü Á¶Àý¼¼Æ÷
immortalized cell
¹«ÇÑÁõ½Ä¼¼Æ÷
immunity,cell-mediated
¼¼Æ÷¸Å°³¼º(á¬øàØÚË¿àõ)
immunocompetent cell
¸é¿ªÀû°Ý¼¼Æ÷.
immunodeficiency syndrome, cell mediated
¼¼Æ÷¸Å°³ ¸é¿ª°áÇÌ ÁõÈıº
immunologically committed cell
¸é¿ª°æÇè¼¼Æ÷(¡ÌèúÐá¬øà).
immunologically competent cell
¸é¿ªÀû°Ý¼¼Æ÷(¡îêÌ«á¬øà).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
cell cycle time
¼¼Æ÷ÁÖ±â½Ã°£
cell death
¼¼Æ÷»ç(á¬øàÞÝ)
cell death
¼¼Æ÷»ç(á¬øàÞÝ).
cell death
¼¼Æ÷»ç (¡ÞÝ)
cell deficiency (aganglionic megacolon)
¼¼Æ÷ÀÌÁÖ°áÇÌ (¹«½Å°æÀýÁÖ¸§Ã¢ÀÚ
cell differentiation
¼¼Æ÷ºÐÈ(¡ÝÂûù)
cell differentiation
¼¼Æ÷ºÐÈ(¡ÝÂûù).
cell distribution
¼¼Æ÷ºÐÆ÷
cell division
¼¼Æ÷ºÐ¿(¡ÝÂæñ)
cell division
¼¼Æ÷ºÐ¿
cell division
¼¼Æ÷ºÐ¿
cell division
¼¼Æ÷ºÐ¿
cell division
¼¼Æ÷ºÐ¿(¡ÝÂæñ).
cell division
¼¼Æ÷ºÐ¿
cell envelope
¼¼Æ÷¿ÜÇÇ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½